Back to discover
Drug

Goserelin

Approved medicine
ResearchOngoing research

Also known as Zoladex, Goserelina.

RxNorm50610UNII0F65R8P09N
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Goserelin
Aliases & brands
ZoladexGoserelina
RxNorm CUI
50610
UNII
0F65R8P09N

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential

Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.

The New England journal of medicine · 1997 · 1,029 cites
Journals, researchers & institutions
Top journals
  • The New England journal of medicine1
Leading researchers
  • Bernier J1
  • Bolla M1
  • Collette L1
  • Dubois JB1
  • Gil T1
  • Gonzalez D1
  • Kuten A1
  • Mirimanoff RO1
Leading institutions
free-text, unnormalised
  • University Hospital1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Cyproterone Acetate

Studied across 2 of the same disease areas as Goserelin in the shared literature.

2 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature